79
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Nomogram for Predicting Risk of Digestive Carcinoma Among Patients with Type 2 Diabetes

ORCID Icon, , , , &
Pages 1763-1770 | Published online: 21 May 2020

References

  • Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010;60(4):207–221. doi:10.3322/caac.20078
  • Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782–787. doi:10.1038/414782a
  • Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer. 2009;16(4):1103–1123. doi:10.1677/ERC-09-0087
  • Renehan A, Smith U, Kirkman MS. Linking diabetes and cancer: a consensus on complexity. Lancet. 2010;9733(375):2201–2202. doi:10.1016/S0140-6736(10)60706-4
  • Wu C-Y, Lin J-T. The changing epidemiology of Asian digestive cancers: from etiologies and incidences to preventive strategies. Best Pract Res Clin Gastroenterol. 2015;29(6):843–853. doi:10.1016/j.bpg.2015.09.016
  • Federation ID. IDF Diabetes Atlas Ninth edition. Available from: https://diabetesatlas.org/en/. Accessed 2019.
  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.29210
  • de Jong RG, Peeters PJ, Burden AM, et al. Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK. Cancer Epidemiol. 2018;54:104–111. doi:10.1016/j.canep.2018.04.008
  • Chiu -C-C, Huang -C-C, Chen Y-C, et al. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan. Intern Med. 2013;52(9):939–946. doi:10.2169/internalmedicine.52.8276
  • Ben Q, Xu M, Ning X, et al. Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer. 2011;47(13):1928–1937. doi:10.1016/j.ejca.2011.03.003
  • Chen H-F, Chen P, Li C-Y. Risk of malignant neoplasm of the pancreas in relation to diabetes: a population-based study in Taiwan. Diabetes Care. 2011;34(5):1177–1179. doi:10.2337/dc10-2006
  • Campbell PT, Deka A, Jacobs EJ, et al. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology. 2010;139(4):1138–1146. doi:10.1053/j.gastro.2010.06.072
  • Wang C, Wang X, Gong G, et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer. 2012;130(7):1639–1648. doi:10.1002/ijc.26165
  • Nitipir C, Barbu MA, Orlov C, et al. Type II diabetes mellitus - associated risk factor in the onset and evolution of digestive tract carcinoma. Rom Biotechnol Lett. 2019;24(1):140–146. doi:10.25083/rbl/24.1/140.146
  • Ma T-M, Sun L-P, Dong -N-N, Sun M-J, Yuan Y. Protein expression trends of DNMT1 in gastrointestinal diseases: from benign to precancerous lesions to cancer. World J Gastrointest Oncol. 2019;11(12):1141–1150. doi:10.4251/wjgo.v11.i12.1141
  • Kirk R. Gastrointestinal cancer: a new dawn for CT scans in colon screening? Nat Rev Clin Oncol. 2012;9(1):6. doi:10.1038/nrclinonc.2012.154
  • Jiao F, Jin Z, Wang L, Wang L. Research and clinical applications of molecular biomarkers in gastrointestinal carcinoma (Review). Biomed Rep. 2013;1(6):819–827. doi:10.3892/br.2013.158
  • Kenner BJ, Chari ST, Cleeter DF, Go VLW. Early detection of sporadic pancreatic cancer: strategic map for innovation—a white paper. Pancreas. 2015;44(5):686. doi:10.1097/MPA.0000000000000369
  • Huang Y-Q, Liang C-H, He L, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157–2164. doi:10.1200/JCO.2015.65.9128
  • Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.9791
  • Harding JL, Shaw JE, Peeters A, Cartensen B, Magliano DJ. Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care. 2015;38(2):264–270. doi:10.2337/dc14-1996
  • Organization WH. Diabetes Mellitus: Report of a WHO Study Group [Meeting Held in Geneva from 11 to 16 February 1985]. WHO; 1985.
  • Taghizadeh N, Vonk JM, Boezen HM. Lifetime smoking history and cause-specific mortality in a cohort study with 43 years of follow-up. PLoS One. 2016;11(4). doi:10.1371/journal.pone.0153310
  • Sauerbrei W, Boulesteix A-L, Binder H. Stability investigations of multivariable regression models derived from low-and high-dimensional data. J Biopharm Stat. 2011;21(6):1206–1231. doi:10.1080/10543406.2011.629890
  • Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247(18):2543–2546. doi:10.1001/jama.1982.03320430047030
  • Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361–387. doi:10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
  • Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008;8(1):53. doi:10.1186/1472-6947-8-53
  • Lee J, Lee SH, Hur KY, Woo SY, Kim SW, Kang WK. Statins and the risk of gastric cancer in diabetes patients. BMC Cancer. 2012;12:596. doi:10.1186/1471-2407-12-596
  • Cheng K-C, Chen Y-L, Lai S-W, Tsai P-Y, Sung F-C. Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in Taiwan. BMC Gastroenterol. 2012;12:177. doi:10.1186/1471-230X-12-177
  • Boursi B, Finkelman B, Giantonio BJ, et al. A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes. Gastroenterology. 2017;152(4):840–850. e843. doi:10.1053/j.gastro.2016.11.046
  • Hsieh M-H, Sun L-M, Lin C-L, et al. Development of a prediction model for colorectal cancer among patients with type 2 diabetes mellitus using a deep neural network. J Clin Med. 2018;7(9):277. doi:10.3390/jcm7090277
  • Hsieh MH, Sun L-M, Lin C-L, Hsieh M-J, Hsu C-Y, Kao C-H. Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models. Cancer Manag Res. 2018;10:6317. doi:10.2147/CMAR.S180791
  • Zheng J, Zhao M, Li J, et al. Obesity-associated digestive cancers: a review of mechanisms and interventions. Tumour Biol. 2017;39(3):1010428317695020. doi:10.1177/1010428317695020
  • Dong Y, Zhou J, Zhu Y, et al. Abdominal obesity and colorectal cancer risk: systematic review and meta-analysis of prospective studies. Biosci Rep. 2017;37(6). doi:10.1042/BSR20170945
  • Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet. 2014;384(9945):755–765. doi:10.1016/S0140-6736(14)60892-8
  • Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–578. doi:10.1016/S0140-6736(08)60269-X
  • Feng R-M, Zong Y-N, Cao S-M, Xu R-H. Current cancer situation in China: good or bad news from the 2018 global cancer statistics? Cancer Commun (Lond). 2019;39(1):22. doi:10.1186/s40880-019-0368-6
  • Shi K, Sun Y. Manual of Medical Oncology (Sixth Edition). China: People’s Medical Publishing House; 2014.
  • Hartgrink HH, Jansen EPM, Grieken NCTV, Velde CJHVD. Gastric cancer. Lancet. 2009;374(9688):477–490. doi:10.1016/S0140-6736(09)60617-6
  • Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–412. doi:10.1016/S0140-6736(12)60643-6
  • Siegel R, Ward E, Brawley O, Jemal A. The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–236. doi:10.3322/caac.20121
  • Cha JM, Jeun JW, Pack KM, Lee JI, Shin WC. Risk of sedation for diagnostic esophagogastroduodenoscopy in obstructive sleep apnea patients. World J Gastroenterol. 2013;19(29):4745–4751. doi:10.3748/wjg.v19.i29.4745
  • Seinel L, Reinikainen P, Ahvenainen J. Effect of upper gastrointestinal endoscopy on cardiopulmonary changes in very old patients. Arch Gerontol Geriatr. 2003;37(1):25–32.
  • Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Br J Surg. 2015;102(3):148–158. doi:10.1002/bjs.9736
  • Van Calster B, Vickers AJ. Calibration of risk prediction models: impact on decision-analytic performance. Med Decis Making. 2015;35(2):162–169. doi:10.1177/0272989X14547233
  • Localio AR, Goodman S. Beyond the usual prediction accuracy metrics: reporting results for clinical decision making. Ann Intern Med. 2012;157(4):294–295. doi:10.7326/0003-4819-157-4-201208210-00014